Colombia Radiotherapy Market Overview, 2031

Key Insights

• The Colombian radiotherapy market operates within a mixed public-private healthcare system, with significant infrastructure deficits relative to cancer burden. A study published in Advances in Radiation Oncology (2021) found that Colombia has 69 linear accelerators, 2 radiosurgery units, and 30 high-dose-rate brachytherapy units as of June 2020, with 12 states home to 3.7 million people lacking any LINACs entirely .
• External Beam Radiotherapy (EBRT) constitutes the largest therapy segment, supported by an installed base of 94 LINACs as of 2024. However, only 69 were operational as of 2020, indicating that 25–30 older units require replacement or are non-functional .
• Radiotherapy systems and equipment represent the largest offering segment, with Colombia importing virtually all its teletherapy machines. The United States, Sweden (Elekta), Germany (Siemens/Varian), and Japan (Accuray) are the principal equipment origins, with import tariffs typically ranging from 5% to 10% ad valorem .
• Hospitals and integrated cancer centres are the largest end-user segment, though geographic distribution is highly concentrated in major cities Bogotá, Medellín, Cali, and Barranquilla. The SES Caldas University Hospital in Manizales represents a recent public-private partnership, having opened a new radiotherapy service in 2023 equipped with a Varian TrueBeam LINAC, Siemens SOMATOM go.Sim CT, and Varian Bravos HDR brachytherapy system .
• Regulatory oversight is provided by INVIMA, which requires sanitary registration for all medical devices. The registration process demands technical documentation including IEC and ISO 60601-series safety standards compliance, with a processing timeline of 3–9 months for initial device clearance .

Market Outlook

• According to the research report, "Colombia Radiotherapy Market Overview, 2031," published by Bonafide Research, the Colombia Radiotherapy market is anticipated to grow at more than 9.50% CAGR from 2026 to 2031. This robust growth trajectory reflects the substantial infrastructure deficit, rising cancer incidence, and significant public and private investment commitments.
• The market is expected to benefit from continued government and private sector investment in radiotherapy infrastructure. The study published in Advances in Radiation Oncology estimates that Colombia requires 147 linear accelerators by 2035 to meet projected disease burden, representing a requirement for an additional 80+ units beyond the 2024 installed base . Projections indicate cumulative procurement of approximately 70–100 units between 2026 and 2035 .
• Technology modernisation is accelerating through private sector investment. Avidanti Clinics, backed by Patria Investments, has opened a new COP 100 billion (USD 25 million) high-complexity clinic in Armenia, Quindío, with COP 70 billion in infrastructure and COP 30 billion in specialised medical equipment . The SES Caldas University Hospital, a public-private partnership, has equipped its Integral Cancer Unit with a Varian TrueBeam LINAC, representing a significant investment in the coffee region .
• The market is also characterised by significant human resource deficits. The Colombian Association of Radiation Oncology has documented that the country requires 246 radiation oncologists, 184 medical physicists, and 491 radiation therapy technologists by 2035, compared with current availability of 124 oncologists, indicating workforce constraints that will drive demand for automated solutions and service partnerships .
• Long-term growth is supported by sustained government commitment. Colombia's goal to increase radiotherapy access from approximately 40% of cancer patients to 60% by 2035 will require 15–25 new treatment rooms and associated equipment . Government procurement is conducted through the Colombia Compra Eficiente platform, with tenders evaluated on technical specification conformance, price, warranty duration, and local service coverage .

Market Dynamics

Driver: Infrastructure Deficit and Expanding Cancer Burden
The primary driver of the Colombian radiotherapy market is the substantial infrastructure deficit relative to the growing cancer burden. Cancer incidence in Colombia is projected to reach 73,684–88,743 cases annually by 2035, compared with approximately 48,000 incident cases in 2020 . The optimal radiotherapy utilisation rate in Colombia is estimated at 48%–53% of incident cancers, yet current megavoltage machine coverage is only 65% of the estimated requirement . The country currently has only 1.3 LINACs per million population, lower than the Latin American upper-middle-income country average of 1.6 . The International Atomic Energy Agency estimates that in low- and middle-income countries, the optimal rate of radiotherapy use is 55% for incident cancers with a 10% probability of retreatment. To manage this population, Colombia would need 97 accelerators for the current burden and 147 to meet the disease burden by 2035 . This 20%–65% equipment deficit creates sustained demand for new equipment, installation services, training, and comprehensive maintenance contracts.

Challenge: Geographic Disparities and Equipment Dependency
A significant challenge facing the Colombian radiotherapy market is the profound regional disparity in equipment availability. Twelve of Colombia's 32 departments, home to 3.7 million people (37.5% of the population), lack any LINACs entirely . The study in Advances in Radiation Oncology documented that radiotherapy services are concentrated in five major cities, creating severe access barriers for patients in the Llanos region and other remote areas . Equipment dependency on imports compounds this challenge: Colombia imports virtually all teletherapy machines, making the market vulnerable to peso depreciation which increases local currency costs and occasionally leads to procurement delays and global supply chain disruptions . The refurbished segment could grow to 15%–20% of annual procurement by 2035 if financing constraints persist . Additionally, workforce shortages the country needs 122 additional radiation oncologists, 121 additional medical physicists, and 216 additional technologists by 2035 limit effective equipment utilisation .



Trend: Public-Private Partnerships and Service Expansion
A major trend shaping the Colombian radiotherapy market is the expansion of services through public-private partnerships and private sector investment. The SES Caldas University Hospital in Manizales, a strategic alliance between public and private stakeholders, opened a new radiotherapy service in 2023 equipped with a Varian TrueBeam LINAC, Siemens SOMATOM go.Sim CT, General Electric Signa Explorer 1.5T MRI, and Varian Bravos HDR brachytherapy system . Avidanti Clinics has opened a COP 100 billion (USD 25 million) high-complexity clinic in Armenia, Quindío, with COP 30 billion in specialised medical equipment, backed by foreign investment through Patria Investments . This trend toward public-private partnerships and private investment is creating new demand for equipment, installation services, training, and comprehensive maintenance contracts, while reducing the burden on public sector budgets.

Policies

• INVIMA (Instituto Nacional de Vigilancia de Medicamentos y Alimentos) regulates medical devices, including radiotherapy equipment. Devices must obtain a Sanitary Registry (Registro Sanitario) before commercialization, with the registration process demanding a technical file including IEC and ISO 60601-series safety standards compliance .
• Colombian Resolution 2013 of 2020 establishes requirements for radiation-emitting equipment, including operator licensing, installation reporting, and annual performance verification by an accredited medical physicist .
• Radiation protection regulations enforced by the Ministry of Mines and Energy govern shielding design and source disposal for cobalt-60 units .
• Government procurement is conducted through the Colombia Compra Eficiente platform for public tenders, with tenders evaluated on technical specification conformance, price, warranty duration, local service coverage, and past performance .
• Foreign manufacturers must designate a local legal representative (usually the distributor) to hold the Sanitary Registry. Failure to maintain updated registrations can halt imports and lead to equipment seizure .
• The Colombian Association of Radiation Oncology (ACRO) provides professional standards and quality assurance protocols that shape technology adoption and treatment delivery patterns .

Segment Analysis

Colombia Radiotherapy Market By Therapy Type
• External Beam Radiotherapy (EBRT): This is the largest therapy segment, supported by the installed base of linear accelerators across public and private facilities. Colombia had 94 LINACs as of 2024, though only 69 were operational as of 2020, with 12 states lacking any LINACs . The SES Caldas University Hospital's Varian TrueBeam LINAC represents advanced EBRT technology, prepared to offer IMRT, IMAT, SRS, and SBRT with image-guided and surface-guided techniques . The segment is driven by the clinical dominance of EBRT for a broad spectrum of malignancies. However, the study in Advances in Radiation Oncology identified that megavoltage machine coverage is only 65% of the estimated requirement .
• Internal / Brachytherapy: This segment is clinically established, particularly for gynaecological cancers including cervical cancer. Colombia had 30 high-dose-rate brachytherapy units as of 2020 . The SES Caldas University Hospital operates a Varian Bravos system with 30 channels for HDR therapy with Ir-192 . This segment faces infrastructure constraints, with brachytherapy services concentrated in major cities and limited availability in underserved regions.
• Systemic Radiotherapy: This is the fastest-growing therapy segment, driven by the emergence of novel radiopharmaceuticals and targeted radionuclide therapies. The segment benefits from Colombia's growing nuclear medicine infrastructure, with hospital nuclear medicine departments and specialised cancer centres driving demand for radioactive iodine ablation therapy and other radiopharmaceuticals . The Colombian market depends on global isotope supply, with supply bottlenecks related to limited global reactor capacity, stringent GMP requirements, and complex cold-chain logistics .

Colombia Radiotherapy Market By Offering
• Radiotherapy Systems/Equipment: This segment holds the largest market share by revenue, driven by high capital costs and significant infrastructure deficits. Colombia imports virtually all teletherapy machines, with the United States (42%), Sweden (Elekta), Germany (Siemens/Varian), and Japan (Accuray) representing the principal origins . Recent procurement demonstrates significant capital expenditure: the SES Caldas University Hospital's radiotherapy service includes a Varian TrueBeam LINAC, Siemens SOMATOM go.Sim CT, GE Signa Explorer 1.5T MRI, and Varian Bravos HDR brachytherapy system . The market is projected to see cumulative procurement of approximately 70–100 units between 2026 and 2035 . Equipment replacement cycles 30–40 older LINACs and cobalt-60 units will exceed 15 years of service by 2030 drive sustained demand .
• Software & Services: This is the fastest-growing segment, reflecting increasing digitalisation of radiation oncology and the aging installed base. The software component includes advanced treatment planning systems the SES Caldas University Hospital's Varian TrueBeam features the Identify system for SGRT, Perfect Pitch, and Respiratory Gating . The services component encompasses installation, comprehensive maintenance, clinical training, and physics support. Distributors that invest in local spare part depots, certified service engineers, and loaner equipment are well-positioned to capture market share .

Colombia Radiotherapy Market By Application
• Breast Cancer: This is a major application segment, with breast cancer ranking among the most frequent malignancies in Colombia. Radiotherapy plays a central role in breast-conserving therapy and post-mastectomy treatment. The optimal utilisation of radiation therapy for breast cancer is well-established in clinical evidence .
• Cervical Cancer: A significant application area, with brachytherapy playing a critical role. Colombia has a high burden of cervical cancer, and the 30 HDR brachytherapy units documented in 2020 represent essential infrastructure for this disease. The study in Advances in Radiation Oncology identified gynaecological cancers as a priority for radiotherapy services .
• Prostate Cancer: A growing application area, with increased adoption of EBRT and advanced techniques. The Varian TrueBeam at SES Caldas University Hospital is equipped for IMRT, IMAT, and SBRT for prostate cancer and other malignancies .
• Lung Cancer: This segment is growing, with increased adoption of stereotactic radiotherapy. Lung cancer is among the main causes of cancer death in Colombia, with optimal radiotherapy utilisation rates indicating significant demand .
• Head & Neck Cancer: This is a critical application requiring highly conformal radiation delivery, driving adoption of IMRT and image-guided techniques. The Varian TrueBeam's image-guided and surface-guided capabilities are particularly beneficial for head and neck cancers .
• Colorectal Cancer: A significant application area, with colorectal cancer among the main causes of cancer death in Colombia. Radiotherapy plays a role in neoadjuvant and adjuvant treatment .
• Other Applications: Includes gastric cancer, which is among the main causes of cancer death in Colombia , as well as haematological malignancies, paediatric cancers, and palliative care indications.

Colombia Radiotherapy Market By End User
• Hospitals & Integrated Cancer Centres: This is the largest end-user segment, operating within the public-private healthcare system. Major centres include the Instituto Nacional de Cancerología and Clínica del Country, which are primary buyers through direct OEM sales . The SES Caldas University Hospital's Integral Cancer Unit, a public-private partnership, represents the expansion of hospital-based radiotherapy services in the coffee region . Government buyers issue public tenders via the Colombia Compra Eficiente platform .
• Standalone Radiotherapy Centres: This segment is growing, particularly through private investment. Avidanti Clinics has opened a COP 100 billion high-complexity clinic in Armenia, Quindío, with COP 30 billion in specialised medical equipment . Private buyers often procure through closed quotations and value-added resellers, with financing options such as leasing or vendor credit increasingly used .
• Academic/Research Institutions: This is the fastest-growing segment, reflecting their central role in workforce development and clinical research. The Colombian Association of Radiation Oncology (ACRO) conducts surveys and provides professional standards . The study in Advances in Radiation Oncology was supported by the National Cancer Institute of Colombia, demonstrating research capacity .
• Other Healthcare Facilities: Includes regional hospitals and community-based centres. However, 12 departments lack any LINACs, creating significant access challenges. The goal to increase radiotherapy access from 40% to 60% of cancer patients by 2035 will require expansion into underserved regions .

Colombia Radiotherapy Market Economics

• Equipment procurement in Colombia is conducted through public tenders via the Colombia Compra Eficiente platform and private direct purchases. The imported teletherapy machine market is sensitive to peso depreciation, which increases local currency costs and occasionally leads to procurement delays .
• Tariff rates for imported teletherapy machines are typically 5% to 10% ad valorem, with possible reductions under free trade agreements such as the U.S.-Colombia Trade Promotion Agreement or the EU-Colombia Trade Agreement .
• INVIMA sanitary registration adds 3–9 months for initial device clearance, adding time and cost to equipment procurement .
• Financing options such as leasing or vendor credit from OEMs are increasingly used to manage high upfront costs, with some tenders requiring bidders to provide financing proposals alongside equipment offers .
• The economic value of radiotherapy is well-recognised. Radiotherapy is cost-effective compared with chemotherapy and generates economic benefits for the health sector when used as adjuvant or curative definitive treatment .
• Equipment downtime directly affects patient access and treatment outcomes. In many Colombian cities, there is only one LINAC, and equipment failures force patients to travel to other regions for treatment .
• The cost of cybersecurity and software modernisation is an emerging factor, with connected radiotherapy devices requiring ongoing patch management and vulnerability remediation.

Market Outlook by Infrastructure, Investment and Industry Development

• The Colombian government has set a goal to increase radiotherapy access from approximately 40% of cancer patients to 60% by 2035, requiring 15–25 new treatment rooms and associated equipment. The study published in Advances in Radiation Oncology estimated that Colombia requires 147 linear accelerators by 2035, compared with 69 operational in 2020 .
• Private sector investment is accelerating. Avidanti Clinics, backed by Patria Investments, has opened a COP 100 billion (USD 25 million) high-complexity clinic in Armenia, Quindío, with COP 30 billion in specialised medical equipment . The SES Caldas University Hospital's Integral Cancer Unit, a public-private partnership, opened in 2023 with a Varian TrueBeam LINAC, Siemens SOMATOM go.Sim CT, and Varian Bravos HDR brachytherapy system .
• The installed base is aging: 30–40 older LINACs and cobalt-60 units will exceed 15 years of service by 2030, generating replacement demand . Cumulative procurement of approximately 70–100 units is projected between 2026 and 2035 .
• Workforce development is a critical priority. The Colombian Association of Radiation Oncology has documented that the country requires 246 radiation oncologists, 184 medical physicists, and 491 radiation therapy technologists by 2035, compared with current availability of 124 oncologists, 121 physicists, and 275 technologists .
• The refurbished segment could grow to 15%–20% of annual procurement by 2035 if financing constraints persist, creating opportunities for service and lifecycle management providers .
• Distributors that invest in local spare part depots, certified service engineers, and loaner equipment are well-positioned to capture market share in the growing maintenance and service segment .
• The long-term outlook remains positive as cancer incidence continues to rise projected to reach 73,684–88,743 cases annually by 2035 and sustained public and private investment drives equipment modernisation, infrastructure expansion, and improved patient access across Colombia's healthcare system. However, addressing geographic disparities, workforce constraints, and import dependency will be essential to ensuring equitable access and treatment continuity across all departments.



Considered in this report
• Historic Year: 2020
• Base year: 2025
• Estimated year: 2026
• Forecast year: 2031

Aspects covered in this report
• Radiotherapy Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Therapy Type
• External Beam Radiotherapy (EBRT)
• Internal / Brachytherapy
• Systemic Radiotherapy

By Offering
• Radiotherapy Systems/Equipment
• Software & Services

By Application
• Breast Cancer
• Prostate Cancer
• Lung Cancer
• Head & Neck Cancer
• Central Nervous System / Brain
• Gastro-intestinal
• Other Applications

By End User

• Hospitals & Integrated Cancer Centers
• Standalone Radiotherapy Centers
• Academic/Research Institutions
• Other Healthcare Facilities